KIDS241220C15000
- 0.00
- 0.000.00%
OrthoPediatrics Newsroom
JMP Securities Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $50
Buy Rating for OrthoPediatrics Driven by Strong Financial Performance and Growth Potential
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating
The Latest Analyst Ratings For OrthoPediatrics
Stifel Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $40
Needham Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $42
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating
Truist Financial Sticks to Their Hold Rating for OrthoPediatrics (KIDS)
JMP Securities Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $50
OrthoPediatrics: Strong Financial Performance and Growth Outlook Reinforce Buy Rating
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Cuts Target Price to $28
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating, Announces Target Price $34
Stifel Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $40
A Quick Look at Today's Ratings for OrthoPediatrics(KIDS.US), With a Forecast Between $34 to $50
OrthoPediatrics (KIDS) Initiated With a Hold at Truist Financial
OrthoPediatrics Analyst Ratings
Buy Rating Reaffirmed for OrthoPediatrics on Robust Growth Strategy and Strong Financials
BTIG Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $44
Piper Sandler Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Raises Target Price to $44
Piper Sandler Reaffirms Their Buy Rating on OrthoPediatrics (KIDS)